Documentation Centre

 

 

  of 110 Next page

Go to page: of

Screenshot Date Categories Title Author Format
An exercise-induced metabolite alters feeding. Nat Rev Endocrinol. 2022;18:521 November 24, 2022 An exercise-induced metabolite alters feeding. Nat Rev Endocrinol. 2022;18:521 Greenhill C Key Publications
Are metabolic adaptations to weight changes an artefact? Am J Clin Nutr. 2021;114:1386-1395 May 25, 2022 Are metabolic adaptations to weight changes an artefact? Am J Clin Nutr. 2021;114:1386-1395 Müller MJ, Heymsfield SB, Bosy-Westphal A Key Publications
Impact of dietary carbohydrate type and protein-carbohydrate interaction on metabolic health. Nat Metab. 2021;3:810-828 January 28, 2022 Impact of dietary carbohydrate type and protein-carbohydrate interaction on metabolic health. Nat Metab. 2021;3:810-828 Wali JA, Milner AJ, Luk AWS, Pulpitel TJ, Dodgson T, Facey HJW, Wahl D, Kebede MA, Senior AM, Sullivan MA, Brandon AE et al. Key Publications
Dietary fat and low fiber in purified diets differently impact the gut-liver axis to promote obesity-linked metabolic impairments. Am J Physiol Gastrointest Liver Physiol. 2021;320:G1014-G1033 January 13, 2022 Dietary fat and low fiber in purified diets differently impact the gut-liver axis to promote obesity-linked metabolic impairments. Am J Physiol Gastrointest Liver Physiol. 2021;320:G1014-G1033 Daniel N, Rossi Perazza L, Varin TV, Trottier J, Marcotte B, St-Pierre P, Barbier O, Chassaing B, Marette A. Key Publications
Metabolism and metabolic disorders and the microbiome: The intestinal microbiota associated with obesity, lipid metabolism, and metabolic health-pathophysiology and therapeutic strategies. Gastroenterology. 2021;160:573-599 June 07, 2021 Metabolism and metabolic disorders and the microbiome: The intestinal microbiota associated with obesity, lipid metabolism, and metabolic health-pathophysiology and therapeutic strategies. Gastroenterology. 2021;160:573-599 Aron-Wisnewsky J, Warmbrunn MV, Nieuwdorp M, Clément K Key Publications
Impact of human visceral and glutealfemoral adipose tissue transplant on glycemic control in a mouse model of diet-induced obesity. Am J Physiol Endocrinol Metab. 2020;319:E519-E528. January 15, 2021 Impact of human visceral and glutealfemoral adipose tissue transplant on glycemic control in a mouse model of diet-induced obesity. Am J Physiol Endocrinol Metab. 2020;319:E519-E528. Tsiloulis T, Raajendiran A, Keenan SN, Ooi G, Taylor RA, Burton P, Watt MJ Key Publications
Dietary sugars alter hepatic fatty acid oxidation via transcriptional and post-translational modifications of mitochondrial proteins. Cell Metab. 2019;30:735-75 April 07, 2020 Dietary sugars alter hepatic fatty acid oxidation via transcriptional and post-translational modifications of mitochondrial proteins. Cell Metab. 2019;30:735-75 Softic S, Meyer JG, Wang GX, Gupta MK, Batista TM, Lauritzen HPMM, Fujisaka S, Serra D, Herrero L, Willoughby J, Fitzgerald K, Ilkayeva O, Newgard CB, Gibson BW, Schilling B, Cohen DE, Kahn CR Key Publications
Sugar-sweetened beverages decrease fat oxidation. Nat Rev Endocrinol. 2019;15:685 April 06, 2020 Sugar-sweetened beverages decrease fat oxidation. Nat Rev Endocrinol. 2019;15:685 Starling S Key Publications
Nonalcoholic fatty liver disease, insulin resistance, and ceramides. N Engl J Med. 2019;381:1866-1869 April 03, 2020 Nonalcoholic fatty liver disease, insulin resistance, and ceramides. N Engl J Med. 2019;381:1866-1869 Samuel VT, Shulman GI Key Publications
Targeting a ceramide double bond improves insulin resistance and hepatic steatosis. Science. 2019;365:386-39 April 03, 2020 Targeting a ceramide double bond improves insulin resistance and hepatic steatosis. Science. 2019;365:386-39 Chaurasia B, Tippetts TS, Mayoral Monibas R, Liu J, Li Y, Wang L, Wilkerson JL, Sweeney CR, Pereira RF, Sumida DH, Maschek JA et al. Key Publications

  of 110 Next page

Go to page: of